In addition, metformin combined with anti-PD-1 therapy promotes the normalization of tumor blood vessels, increases the expression of vascular endothelial cadherin (VE-cadherin) and vascular cell adhesion molecule 1(VCAM-1), and infiltration of CD8+ T cells, and slows tumor growth (32). Here, CDH5 is linked to neoplasm.